REVANCE THERAPEUTICS INC's ticker is RVNC and the CUSIP is 761330109. A total of 222 filers reported holding REVANCE THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.25 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $497,528 | -78.7% | 193,591 | -27.2% | 0.00% | -81.2% |
Q4 2023 | $2,338,481 | +1.1% | 266,039 | +31.9% | 0.02% | -11.1% |
Q3 2023 | $2,312,741 | +8.8% | 201,634 | +140.0% | 0.02% | 0.0% |
Q2 2023 | $2,126,040 | +20.0% | 84,000 | +52.7% | 0.02% | +5.9% |
Q1 2023 | $1,771,582 | -44.0% | 55,001 | -67.9% | 0.02% | -34.6% |
Q4 2022 | $3,163,139 | -46.0% | 171,351 | -21.0% | 0.03% | -46.9% |
Q3 2022 | $5,857,000 | +1899.0% | 216,899 | +2090.9% | 0.05% | +1533.3% |
Q2 2021 | $293,000 | -88.6% | 9,900 | -88.2% | 0.00% | -98.4% |
Q1 2018 | $2,578,000 | -24.4% | 83,700 | -12.2% | 0.19% | -30.8% |
Q4 2017 | $3,409,000 | – | 95,357 | – | 0.28% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Essex Woodlands Management, Inc. | 4,592,047 | $121,230,000 | 21.92% |
Rhenman & Partners Asset Management AB | 220,000 | $5,808,000 | 0.83% |
ArrowMark Colorado Holdings LLC | 2,045,862 | $54,011,000 | 0.67% |
Vivo Capital, LLC | 77,373 | $2,043,000 | 0.52% |
Ghost Tree Capital, LLC | 89,295 | $2,357,000 | 0.49% |
ESSEX INVESTMENT MANAGEMENT CO LLC | 124,932 | $3,298,000 | 0.47% |
Polar Capital LLP | 1,296,371 | $34,220,000 | 0.46% |
SUFFOLK CAPITAL MANAGEMENT LLC | 70,095 | $1,851,000 | 0.24% |
EAM Investors, LLC | 33,897 | $895,000 | 0.15% |
PointState Capital LP | 438,200 | $11,568,000 | 0.13% |